One of the keys to this therapy from my understanding is in previous animal tests the therapy activated the immune system to recognise and attack the cancer once reintroduced back into the animal model.
It looks incredibly promising in combo with IMU's OnCARlytics IMO.
GLTAH & IMO
AFR - Why analysts love these eight medtech stocks, page-4
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
-0.005(3.23%) |
Mkt cap ! $157.6M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 15.5¢ | 15.0¢ | $63.39K | 414.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 384976 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 228483 | 5 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| ALA (ASX) Chart |